Enthorin Therapeutics Revenue
Biotechnology Research • • 1-10 Employees
$
Enthorin Therapeutics revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at Enthorin Therapeutics
Michael Yassa
Co-Founder
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
About Enthorin Therapeutics
Enthorin Therapeutics is a clinical stage pharmaceutical company founded with the goal of developing innovative therapeutics that target brain circuit dysfunction to improve quality of life for patients, families, and communities.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
Enthorin Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Enthorin Therapeutics has never raised funding before.
United Arab Emirates
Netherlands
Poland
CanadaFrequently asked questions
Enthorin Therapeutics is located in XX.
Enthorin Therapeutics generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.
Enthorin Therapeutics has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Enthorin Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
